HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Camlin Tierney Selected Research

efavirenz (Sustiva)

10/2021Transportability From Randomized Trials to Clinical Care: On Initial HIV Treatment With Efavirenz and Suicidal Thoughts or Behaviors.
1/2019Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.
12/2017Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.
1/2017Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
3/2015Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.
7/2014Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.
7/2012Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.
10/2011Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
6/2011Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.
12/2009Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Camlin Tierney Research Topics

Disease

17Acquired Immunodeficiency Syndrome (AIDS)
01/2019 - 12/2004
5HIV Infections (HIV Infection)
10/2021 - 07/2002
4Infections
03/2018 - 02/2006
3Inflammation (Inflammations)
11/2017 - 07/2012
3Hepatitis C
01/2016 - 12/2012
2Disease Progression
01/2021 - 01/2003
2Hepatitis B
03/2018 - 01/2016
1Infant Death
01/2022
1Neutropenia
01/2021
1Severe Acute Malnutrition
01/2021
1Immune Reconstitution Inflammatory Syndrome
11/2017
1Proteinuria
09/2014
1Albuminuria
09/2014
1Insulin Resistance
06/2014
1Chronic Renal Insufficiency
03/2014
1Hyperbilirubinemia
02/2013
1Leukocytosis (Pleocytosis)
07/2007
1Viremia
02/2006

Drug/Important Bio-Agent (IBA)

12efavirenz (Sustiva)FDA Link
10/2021 - 12/2004
10Ritonavir (Norvir)FDA Link
01/2021 - 12/2009
8lamivudine drug combination abacavirFDA Link
01/2019 - 12/2009
8Emtricitabine (Emtriva)FDA Link
01/2019 - 12/2009
8Tenofovir (Viread)FDA Link
01/2019 - 12/2009
8Atazanavir Sulfate (Reyataz)FDA Link
01/2019 - 12/2009
4RacivirIBA
01/2022 - 10/2011
4Biomarkers (Surrogate Marker)IBA
11/2017 - 07/2007
3Protease Inhibitors (Protease Inhibitor)IBA
01/2019 - 12/2009
3RNA (Ribonucleic Acid)IBA
11/2013 - 01/2003
3NucleosidesIBA
12/2009 - 07/2002
2LopinavirFDA Link
01/2021 - 01/2015
2Alanine Transaminase (SGPT)IBA
01/2021 - 01/2016
2Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
03/2018 - 01/2016
2Immunoglobulins (Immunoglobulin)IBA
03/2018 - 01/2016
2Hepatitis B e AntigensIBA
03/2018 - 01/2016
2CreatinineIBA
01/2016 - 03/2014
2Cystatin CIBA
06/2015 - 03/2014
2Reverse Transcriptase InhibitorsIBA
09/2014 - 12/2009
1Zidovudine (Retrovir)FDA LinkGeneric
01/2021
1Nevirapine (Viramune)FDA Link
01/2021
1Lamivudine (Epivir)FDA Link
01/2021
1CytokinesIBA
11/2017
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2016
1Antiviral Agents (Antivirals)IBA
01/2016
1hepatitis B hyperimmune globulinIBA
01/2016
1Pharmaceutical PreparationsIBA
12/2015
1Proteins (Proteins, Gene)FDA Link
12/2015
1NucleotidesIBA
09/2014
1Glucose (Dextrose)FDA LinkGeneric
06/2014
1Insulin (Novolin)FDA Link
06/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2014
1Cell Adhesion MoleculesIBA
02/2014
1Interleukin-6 (Interleukin 6)IBA
02/2014
1C-Reactive ProteinIBA
02/2014
1Cytochrome P-450 CYP3AIBA
04/2013
1Pregnane X ReceptorIBA
04/2013
1Peptide Hydrolases (Proteases)FDA Link
12/2012
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2012
1Amino AcidsFDA Link
12/2012
1InterferonsIBA
02/2006
1EnzymesIBA
02/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2003

Therapy/Procedure

10Therapeutics
01/2021 - 07/2002
3Art Therapy
01/2021 - 09/2014
3Highly Active Antiretroviral Therapy (HAART)
01/2011 - 02/2006
1Aftercare (After-Treatment)
02/2006